Market Overview:
The global topical pain management therapeutics market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic pain, rising geriatric population, and growing demand for minimally invasive procedures. Based on type, the global topical pain management therapeutics market is segmented into anesthetics, analgesics, and skeletal muscle relaxants. Anesthetics are further sub-segmented into general anesthetics and local anesthetics. Analgesics are further sub-segmented into opioid analgesics and non-opioid analgesics. Skeletal muscle relaxants are further sub-segmented into centrally acting skeletal muscle relaxants and peripherally acting skeletal muscle relaxants. Based on application, the global topical pain management therapeutics market is segmented into hospital pharmacies, drug stores, online pharmacies,.and others (including clinics and veterinary hospitals). Geographically, the global topical pain management therapeutics market is segmented into North America,, Latin America,, Europe,, Asia Pacific,,and Middle East & Africa,. Some of the key players operating in this market include Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc., Sanofi S.A.
Product Definition:
Topical pain management therapeutics are medications and other treatments that can be applied to the skin in order to relieve pain. They can be used for a variety of conditions, including but not limited to: muscle aches, joint pain, headaches, and menstrual cramps. Topical analgesics work by blocking the transmission of pain signals from the affected area to the brain.
Anesthetics:
Anesthetics is a class of drugs that acts as an blockage to pain signals. It may be used for surgical procedures or accidental injuries. The most common uses of anesthetics are during dentistry, dental anesthesia, and pain management before surgeries.
Analgesics:
Analgesics are the drugs that provide temporary relief from pain. The most commonly used analgesic is acetaminophen (APAP), which is a widely prescribed pain-relieving drug, especially in cases of acute back and neck pain, arthritis Pain Management Topical Analgesics Market Size & Forecast by End Use (Hospitals/Clinics, Ambulatory Surgical Centers) and by Region. It works by decreasing the perception of painful sensation to the brain.
Application Insights:
Based on the application, the market is segmented into hospital pharmacies, drug stores and online pharmacies. In 2017, hospital pharmacies held a major share of the topical pain management therapeutics market owing to factors such as high usage rates of topical analgesics for acute pain conditions in hospitals.
The growing prevalence of chronic diseases and rising geriatric population are expected to drive demand for drugs with higher efficiency and lower side effects compared to other conventional medicines. This trend is likely to benefit product penetration in near future. Moreover, increasing R&D investments by pharmaceutical companies for developing new topically applied analgesic drugs with enhanced efficiency is further anticipated to fuel industry growth over the forecast period.
Drug stores are projected register significant gains over the forecast period due largely on account of increasing adoption rate among healthcare professionals regarding its effectiveness in treating various types of chronic pains including neurogenic & arthritis related pains along with reducing inflammation & swelling caused due these disorders.
Regional Analysis:
North America dominated the market in 2017 owing to the presence of a large number of key players and well-established healthcare infrastructure. Moreover, an increase in sports injuries and prevalence of chronic pain conditions are also contributing towards regional growth. According to a study published by National Center for Health Statistics (NCHS), from 2015 to 2016, around 16% adults were suffering from pain that required top treatment with opioid analgesics or stronger. In addition, easy availability of insurance coverage is further boosting this region’s growth prospects.
Asia Pacific is expected to witness lucrative CAGR over the forecast period due to rising disposable income levels and improving healthcare facilities in emerging economies such as India & China & Indonesia etc., which are attracting many international pharmaceutical companies for setting up their manufacturing units/ plants/pharmacies etc.
Growth Factors:
- Increasing incidence of chronic pain: The global prevalence of chronic pain is estimated to be around 20%, and it is projected to increase to 30% by 2030. This will create a large pool of patients who will require treatment for their chronic pain, thereby driving the demand for topical pain management therapeutics.
- Growing awareness about the benefits of topical analgesics: There is a growing awareness among patients and healthcare professionals about the benefits of using topical analgesics over oral medications for treating various types of pain. This is likely to boost the demand for these products in the coming years.
- Rising number of product approvals: The number of product approvals by regulatory agencies such as FDA has been increasing in recent years, which is indicativeof growing interest in this area among pharmaceutical companies and investors alike. This will provide a boost tothe growth prospectsof the marketin future years..
Scope Of The Report
Report Attributes
Report Details
Report Title
Topical Pain Management Therapeutics Market Research Report
By Type
Anesthetics, Analgesics, Skeletal Muscle Relaxants
By Application
Hospital Pharmacies, Drug Stores, Online pharmacies
By Companies
Pfizer, GlaxoSmithKline, Endo Pharmaceuticals, Johnson & Johnson Services, Hisamitsu Pharmaceutical, Teva Pharmaceutical Industries, Beiersdorf, Mayne Pharma Group Limited, Sanofi, Topical BioMedics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Topical Pain Management Therapeutics Market Report Segments:
The global Topical Pain Management Therapeutics market is segmented on the basis of:
Types
Anesthetics, Analgesics, Skeletal Muscle Relaxants
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Drug Stores, Online pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- GlaxoSmithKline
- Endo Pharmaceuticals
- Johnson & Johnson Services
- Hisamitsu Pharmaceutical
- Teva Pharmaceutical Industries
- Beiersdorf
- Mayne Pharma Group Limited
- Sanofi
- Topical BioMedics
Highlights of The Topical Pain Management Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Anesthetics
- Analgesics
- Skeletal Muscle Relaxants
- By Application:
- Hospital Pharmacies
- Drug Stores
- Online pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Topical Pain Management Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Topical pain management therapies are medications that are applied to the skin. They can be used to treat a variety of conditions, including pain from arthritis, headaches, and menstrual cramps.
Some of the major players in the topical pain management therapeutics market are Pfizer, GlaxoSmithKline, Endo Pharmaceuticals, Johnson & Johnson Services, Hisamitsu Pharmaceutical, Teva Pharmaceutical Industries, Beiersdorf, Mayne Pharma Group Limited, Sanofi, Topical BioMedics.
The topical pain management therapeutics market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Topical Pain Management Therapeutics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Topical Pain Management Therapeutics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Topical Pain Management Therapeutics Market - Supply Chain
4.5. Global Topical Pain Management Therapeutics Market Forecast
4.5.1. Topical Pain Management Therapeutics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Topical Pain Management Therapeutics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Topical Pain Management Therapeutics Market Absolute $ Opportunity
5. Global Topical Pain Management Therapeutics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Topical Pain Management Therapeutics Market Size and Volume Forecast by Type
5.3.1. Anesthetics
5.3.2. Analgesics
5.3.3. Skeletal Muscle Relaxants
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Topical Pain Management Therapeutics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Topical Pain Management Therapeutics Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Drug Stores
6.3.3. Online pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Topical Pain Management Therapeutics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Topical Pain Management Therapeutics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Topical Pain Management Therapeutics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Topical Pain Management Therapeutics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Topical Pain Management Therapeutics Demand Share Forecast, 2019-2026
9. North America Topical Pain Management Therapeutics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Topical Pain Management Therapeutics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Topical Pain Management Therapeutics Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Drug Stores
9.4.3. Online pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Topical Pain Management Therapeutics Market Size and Volume Forecast by Type
9.7.1. Anesthetics
9.7.2. Analgesics
9.7.3. Skeletal Muscle Relaxants
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Topical Pain Management Therapeutics Demand Share Forecast, 2019-2026
10. Latin America Topical Pain Management Therapeutics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Topical Pain Management Therapeutics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Topical Pain Management Therapeutics Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Drug Stores
10.4.3. Online pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Topical Pain Management Therapeutics Market Size and Volume Forecast by Type
10.7.1. Anesthetics
10.7.2. Analgesics
10.7.3. Skeletal Muscle Relaxants
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Topical Pain Management Therapeutics Demand Share Forecast, 2019-2026
11. Europe Topical Pain Management Therapeutics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Topical Pain Management Therapeutics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Topical Pain Management Therapeutics Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Drug Stores
11.4.3. Online pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Topical Pain Management Therapeutics Market Size and Volume Forecast by Type
11.7.1. Anesthetics
11.7.2. Analgesics
11.7.3. Skeletal Muscle Relaxants
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Topical Pain Management Therapeutics Demand Share, 2019-2026
12. Asia Pacific Topical Pain Management Therapeutics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Topical Pain Management Therapeutics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Topical Pain Management Therapeutics Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Drug Stores
12.4.3. Online pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Topical Pain Management Therapeutics Market Size and Volume Forecast by Type
12.7.1. Anesthetics
12.7.2. Analgesics
12.7.3. Skeletal Muscle Relaxants
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Topical Pain Management Therapeutics Demand Share, 2019-2026
13. Middle East & Africa Topical Pain Management Therapeutics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Topical Pain Management Therapeutics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Topical Pain Management Therapeutics Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Drug Stores
13.4.3. Online pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Topical Pain Management Therapeutics Market Size and Volume Forecast by Type
13.7.1. Anesthetics
13.7.2. Analgesics
13.7.3. Skeletal Muscle Relaxants
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Topical Pain Management Therapeutics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Topical Pain Management Therapeutics Market: Market Share Analysis
14.2. Topical Pain Management Therapeutics Distributors and Customers
14.3. Topical Pain Management Therapeutics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pfizer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. GlaxoSmithKline
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Endo Pharmaceuticals
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Johnson & Johnson Services
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Hisamitsu Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Teva Pharmaceutical Industries
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Beiersdorf
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Mayne Pharma Group Limited
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Sanofi
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Topical BioMedics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
